Use access key #2 to skip to page content.
$18.74 1.18 (6.72%)
10/13/2008 12:00 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BMY

Add Stock to Watchlist

What the Community Thinks

Total Members

823 Outperforms
89 Underperforms
 

All-Stars

205 Outperforms
16 Underperforms
 

Wall Street

17 Outperforms
1 Underperforms
 

Members bullish on BMY are also bullish on:

Members bearish on BMY are also bearish on:

Ticker Tags

Big Pharma (12), New York (30), S&P 500 (472), Large Cap (467), Six Sigma® (37), Drug Manufacturers - Major (27), Dividend (206)
Suggest a tag

Bristol-Myers Squibb Co. At A Glance

Current Price: $18.74
Last Trade Time: 10/13/2008 12:00 PM
Open: $18.23
Previous Close: $17.56
Daily Range: $18.10 - $19.05
52-Week Range: $16.00 - $30.23
Volume: 8,471,559
Market Cap: $41.57B
P/E Ratio: 19.27
Compare Our Special Broker Offers!

Stock Trends

BMY VS S&P 500 (SPY)

BMY 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for BMY

More Headlines...

Top Bull Pitch

Recs

7

Bristol-Myers Squibb Co. (BMY)

Avatar proudfather (< 20) Submitted: 6/11/08 6:09 PM

Bristol Myers is way over-sold at $20. It has not traded below $20 since 1996 and has met resistance at the $20 level on numerous occasions since then. Basic fundamentals are sound. Price/Sales could be a bit lower, but I think the "price" is not the problem, but rather "sales," which seem to hav...More

Replies: 2 | Reply | Permalink

Top Bear Pitch

Recs

1

Bristol-Myers Squibb Co. (BMY)

Avatar danblanchard (< 20) Submitted: 12/31/07 3:01 PM

More layoffs to come...

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 137 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (BMY)

Avatar stockworldpicks (34.77) Submitted: 10/08/08 8:52 PM : Outperform Start Price: $18.52 BMY Score: 5.77

Great Pipeline





Great Yield





Enfamil-Great Cash Flow








Check out my blog :





http://stockworldpicks.blogspot.com

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar ikkyu2 (99.50) Submitted: 10/07/08 11:24 PM : Outperform Start Price: $18.52 BMY Score: 3.55

I can't see how I'm the score leader on this stock. I just gamed around on CAPS with one outperform pick and yanked it when the S+P cratered out from under.

Still, it's a great company. It's not like global demand for medicines is going to slacken any time soon.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar aracer (81.72) Submitted: 10/06/08 2:24 PM : Outperform Start Price: $19.24 BMY Score: 3.58

Good pharma company at great entry point.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar FoolishBri007 (49.66) Submitted: 10/02/08 9:04 PM : Outperform Start Price: $20.56 BMY Score: 7.16

Health care is more important now

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar topherquinn (< 20) Submitted: 9/26/08 4:31 PM : Outperform Start Price: $20.25 BMY Score: 12.82

Durable name in the pharma industry that is in the position to take advantage of the market downturn and acquire compelling products that can add tremendous acceleration to EPS growth. The dividend is in the 6% range, and with reinvestments this will enhance cost averaging and overall investment growth.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 137 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 18 of 18  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackZacks < 20 07/25/08 Outperform 3M $21.81-13.95%-24.09%+10.15 Toggle the visibility of 60-Second Pitch and replies
TrackBerkowitz 85.72 05/27/08 Outperform 1Y $21.06-10.89%-30.91%+20.02 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 82.29 12/17/07 Outperform 3W $26.31-28.66%-34.37%+5.71
TrackEveillard 83.73 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 96.26 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackRichPzena 23.58 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackBillNygren 94.93 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 99.45 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackHAndW < 20 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 99.00 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 93.52 09/30/07 Outperform NS $27.00-30.49%-37.60%+7.11 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 88.02 06/25/07 Outperform NS $29.70-36.81%-36.63%-0.18
TrackCitigroup < 20 06/13/07 Outperform NS $27.14-30.84%-36.74%+5.90
TrackDeutscheSec < 20 04/30/07 Outperform NS $27.40-31.50%-36.37%+4.88
TrackHSBC 89.36 04/27/07 Underperform NS $27.08-30.70%-36.14%-5.44
TrackUBS 82.74 03/01/07 Outperform NS $24.14-22.24%-31.67%+9.43
TrackLehmanBros 76.92 01/12/07 Outperform NS $24.25-22.59%-32.99%+10.40

Results 1 - 18 of 18  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners